Related Experiment Video
Updated: May 15, 2026

Left Atrial Ligation in the Avian Embryo as a Model for Altered Hemodynamic Loading During Early Vascular Development
Published on: June 16, 2023
Cardiac function in congenital adrenal hyperplasia: a pattern of reversible cardiomyopathy
Mary S Minette1, Andrew W Hoyer, Phat P Pham
1Division of Pediatric Cardiology, Department of Pediatrics, Oregon Health & Science University, Portland, OR 97239, USA. minettem@ohsu.edu
Insights
Newborns with congenital adrenal hyperplasia (CAH) show cardiac dysfunction that improves with corticosteroid therapy. This suggests corticosteroids directly impact newborn heart function.
Area of Science:
- Pediatric Endocrinology
- Neonatal Cardiology
- Pediatric Cardiology
Background:
- Congenital adrenal hyperplasia (CAH) can affect multiple organ systems.
- Cardiac function in infants with CAH requires further investigation.
- The impact of corticosteroid replacement on neonatal cardiac health is not fully understood.
Purpose of the Study:
- To assess cardiac function in infants diagnosed with congenital adrenal hyperplasia (CAH).
- To evaluate the effects of corticosteroid replacement therapy on cardiac parameters in infants with CAH.
- To compare cardiac function in infants with CAH to a healthy control group.
Main Methods:
- Prospective case-control study involving 9 infants with CAH and 6 healthy term infants.
- Echocardiography was performed at presentation and after corticosteroid replacement therapy in infants with CAH.
- Cardiac function was assessed using fractional shortening (FS), velocity of circumferential fiber shortening (Vcf), wall stress, and other echocardiographic indices.
Main Results:
- Infants with CAH presented with myocardial dysfunction and lower systolic blood pressure (SBP) compared to controls.
- Fractional shortening (FS) and Vcf significantly improved after corticosteroid treatment in infants with CAH.
- Systolic blood pressure (SBP) also increased significantly following corticosteroid therapy in the CAH group.
Conclusions:
- Newborns with CAH exhibit cardiac dysfunction at baseline.
- Corticosteroid replacement therapy effectively reverses cardiac dysfunction in infants with CAH.
- These findings indicate a direct role for corticosteroids in modulating cardiac function in newborns.
Objective:
To evaluate cardiac function in infants with congenital adrenal hyperplasia (CAH) before and after corticosteroid replacement therapy.
Study Design:
This prospective, case-control study included 9 infants with CAH. Cardiac function was assessed by echocardiography at presentation and after corticosteroid replacement therapy. Six term infants underwent 2 echocardiograms each and served as the control group. Data on fractional shortening (FS), rate-corrected velocity of circumferential fiber shortening (Vcf), wall stress, tissue Doppler indices, myocardial performance index, left ventricular mass, and Vcf/wall stress were obtained.
Results:
The infants with CAH exhibited myocardial dysfunction at baseline and lower systolic blood pressure (SBP) compared with the control group. FS, a measure of systolic contractility, differed significantly from before to after corticosteroid treatment (mean, 32.3%±4.7% pretreatment, 39.9%±5.0% posttreatment). Vcf, a preload-independent measure of cardiac contractility, also differed significantly before and after treatment (mean, 1.23±0.16 circumferences/second pretreatment, 1.45±0.22 circumferences/second posttreatment). SBP was also lower (mean, 84±9.3 mmHg) and improved with treatment (mean, 95±4.8 mmHg). The control group demonstrated no statistically significant changes in FS, Vcf, or SBP. There was a change in left ventricular mass in the control group between the 2 studies.
Conclusion:
Newborns with CAH have evidence for cardiac dysfunction at baseline that reverses with corticosteroid replacement therapy. These data suggest that corticosteroids play a direct role in modulating cardiac function in the newborn.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
